Hebei Changshan Biochemical Pharmaceutical announced that its wholly-owned subsidiary Hebei Changshan Kaikude Biotechnology Co., Ltd. recently received the 'Drug GMP Certificate' issued by the Croatian Agency for Medicinal Products and Medical Devices, certifying the product as crude heparin sodium. This is the first time that Kaikude has passed the EU GMP certification. This certification indicates that the product complies with EU GMP standards, which will help the company expand overseas markets and enhance market competitiveness. Although the impact on the company's performance in the short term is not significant, it is beneficial for long-term development. The company notes that drug exports are easily affected by policies, exchange rates, and market competition, so investors need to make decisions carefully.